Global Male Breast Cancer Market Research Report Information By Type (Infiltrating Ductal Carcinoma, Inflammatory Breast Cancer, Paget Disease, Ductal Carcinoma), by Diagnosis (Mammography, Biopsy, Pet Scan, Others), by Treatment (Local, Systemic) – Forecast Till 2032

Table of Contents:

Chapter 1. Report Prologue

Chapter 2. Market Introduction

2.1 Definition

2.2 Scope of the Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

Chapter 3. Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

Chapter 4. Market Dynamics

4.1 Drivers

4.2 Restraints

4.3 Opportunities

4.4 Challenges

4.5 Macroeconomic Indicators

4.6 Technology Trends & Assessment

Chapter 5. Market Factor Analysis

5.1 Porter’s Five Forces Analysis

5.1.1 Bargaining Power of Suppliers

5.1.2 Bargaining Power of Buyers

5.1.3 Threat of New Entrants

5.1.4 Threat of Substitutes

5.1.5 Intensity of Rivalry

5.2 Value Chain Analysis

5.3 Investment Feasibility Analysis

5.4 Pricing Analysis

Chapter 6. Global Male Breast Cancer Market, by Type

6.1 Introduction

6.2 Ductal Carcinoma in Situ

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

6.3 Paget’s Disease of the Nipple

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

6.4 Inflammatory Breast Cancer

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

6.5 Infiltrating Ductal Carcinoma

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

6.6 Others

Chapter 7. Global Male Breast Cancer Market, by Diagnosis

7.1 Introduction

7.2 Mammography

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

7.3 Biopsy

7.3.1 Fine-Needle Aspiration Biopsy

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

7.3.2 Core Biopsy

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

7.3.3 Excisional Biopsy

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

7.4 PET Scan

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

7.5 CT Scan

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

7.6 MRI Scan

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

7.7 Other Tests

Chapter 8. Global Male Breast Cancer Market, by Treatment

8.1 Introduction

8.2 Local Treatments

8.2.1 Surgery

8.2.1.1 Mastectomy

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

8.2.1.2 Breast-Conserving Surgery (BCS)

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

8.2.1.3 Lymph Nodes Biopsy

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

8.2.2 Radiation Therapy

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

8.3 Systemic Treatments

8.3.1 Chemotherapy

8.3.1.1 Adjuvant Therapy

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

8.3.1.2 Neoadjuvant Therapy

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

8.3.2 Hormone Therapy

8.3.2.1 Using Drugs

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

8.3.2.2 Orchiectomy (Castration)

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

8.3.3 Targeted Therapy

8.3.3.1 For HER2 Positive Breast Cancer

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

8.3.3.2 For Hormone Receptor Positive Breast Cancer

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

8.3.3.3 For Cancer with BRCA Mutations

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

Chapter 9. Global Male Breast Cancer Market, by Region

9.1 Introduction

9.2 Americas

9.2.1 North America

9.2.1.1 US

9.2.1.2 Canada

9.2.2 South America

9.3 Europe

9.3.1 Western Europe

9.3.1.1 Germany

9.3.1.2 France

9.3.1.3 Italy

9.3.1.4 Spain

9.3.1.5 UK

9.3.1.6 Rest of Western Europe

9.3.2 Eastern Europe

9.4 Asia-Pacific

9.4.1 Japan

9.4.2 China

9.4.3 India

9.4.4 Australia

9.4.5 South Korea

9.4.6 Rest of Asia-Pacific

9.5 Middle East & Africa

9.5.1 Middle East

9.5.2 Africa

Chapter 10. Company Landscape

10.1 Introduction

10.2 Market Share Analysis

10.3 Key Development & Strategies

Chapter 11. Company Profiles

11.1 Achieve Life Sciences, Inc.

11.1.1 Company Overview

11.1.2 Product Overview

11.1.3 Financials Overview

11.1.4 Key Developments

11.1.5 SWOT Analysis

11.2 Pfizer Inc.

11.2.1 Company Overview

11.2.2 Product Overview

11.2.3 Financial Overview

11.2.4 Key Developments

11.2.5 SWOT Analysis

11.3 Eli Lilly and Company

11.3.1 Company Overview

11.3.2 Product Overview

11.3.3 Financial Overview

11.3.4 Key Development

11.3.5 SWOT Analysis

11.4 Bristol-Myers Squibb Company

11.4.1 Company Overview

11.4.2 Product Overview

11.4.3 Financial Overview

11.4.4 Key Development

11.4.5 SWOT Analysis

11.5 F. Hoffman-La Roche Ltd.

11.5.1 Company Overview

11.5.2 Product Overview

11.5.3 Financial overview

11.5.4 Key Developments

11.5.5 SWOT Analysis

11.6 Sanofi

11.6.1 Company Overview

11.6.2 Product Overview

11.6.3 Financial Overview

11.6.4 Key Developments

11.6.5 SWOT Analysis

11.7 Novartis AG

11.7.1 Overview

11.7.2 Product Overview

11.7.3 Financial Overview

11.7.4 Key Developments

11.7.5 SWOT Analysis

11.8 BioNumerik Pharmaceuticals Inc.

11.8.1 Overview

11.8.2 Product Overview

11.8.3 Financials

11.8.4 Key Developments

11.8.5 SWOT Analysis

11.9 Seattle Genetics, Inc.

11.9.1 Overview

11.9.2 Product Overview

11.9.3 Financials

11.9.4 Key Developments

11.9.5 SWOT Analysis

11.10 GlaxoSmithKline Plc.

11.10.1 Overview

11.10.2 Product Overview

11.10.3 Financials

11.10.4 Key Developments

11.10.5 SWOT Analysis

11.11 Teva Pharmaceutical Industries Ltd.

11.11.1 Overview

11.11.2 Product Overview

11.11.3 Financials

11.11.4 Key Developments

11.11.5 SWOT Analysis

11.12 Sun Pharmaceutical Industries Ltd.

11.12.1 Overview

11.12.2 Product Overview

11.12.3 Financials

11.12.4 Key Developments

11.12.5 SWOT Analysis

11.13 AstraZeneca

11.13.1 Overview

11.13.2 Product Overview

11.13.3 Financials

11.13.4 Key Developments

11.13.5 SWOT Analysis

11.14 Accord Healthcare

11.14.1 Overview

11.14.2 Product Overview

11.14.3 Financials

11.14.4 Key Developments

11.14.5 SWOT Analysis

11.15 Bayer AG

11.15.1 Overview

11.15.2 Product Overview

11.15.3 Financials

11.15.4 Key Developments

11.15.5 SWOT Analysis

Chapter 12 MRFR Conclusion

12.1 Key Findings

12.1.1 From CEO’s Viewpoint

12.1.2 Unmet Needs of the Market

12.2 Key Companies to Watch

12.3 Predictions for the Male Breast Cancer Industry

Chapter 13. Appendix

LIST OF TABLES

Table 1 Global Male Breast Cancer Market Synopsis, 2020–2027

Table 2 Global Male Breast Cancer Market Estimates and Forecast, 2020–2027 (USD Million)

Table 3 Global Male Breast Cancer Market, by Region, 2020–2027 (USD Million)

Table 4 Global Male Breast Cancer Market, by Type, 2020–2027 (USD Million)

Table 5 Global Male Breast Cancer Market, by Diagnosis, 2020–2027(USD Million)

Table 6 Global Male Breast Cancer Market, by Treatment, 2020–2027 (USD Million)

Table 7 North America: Male Breast Cancer Market, by Type, 2020–2027 (USD Million)

Table 8 North America: Male Breast Cancer Market, by Diagnosis, 2020–2027 (USD Million)

Table 9 North America: Male Breast Cancer Market, by Treatment, 2020–2027 (USD Million)

Table 10 US: Male Breast Cancer Market, by Type, 2020–2027 (USD Million)

Table 11 US: Male Breast Cancer Market, by Diagnosis, 2020–2027 (USD Million)

Table 12 US: Male Breast Cancer Market, by Treatment, 2020–2027 (USD Million)

Table 13 Canada: Male Breast Cancer Market, by Type, 2020–2027 (USD Million)

Table 14 Canada: Male Breast Cancer Market, by Diagnosis, 2020–2027 (USD Million)

Table 15 Canada: Male Breast Cancer Market, by Treatment, 2020–2027 (USD Million)

Table 16 South America: Male Breast Cancer Market, by Type, 2020–2027 (USD Million)

Table 17 South America: Male Breast Cancer Market, by Diagnosis, 2020–2027 (USD Million)

Table 18 South America: Male Breast Cancer Market, by Treatment, 2020–2027 (USD Million)

Table 19 Europe: Male Breast Cancer Market, by Type, 2020–2027 (USD Million)

Table 20 Europe: Male Breast Cancer Market, by Diagnosis, 2020–2027 (USD Million)

Table 21 Europe: Male Breast Cancer Market, by Treatment, 2020–2027 (USD Million)

Table 22 Western Europe: Male Breast Cancer Market, by Type, 2020–2027 (USD Million)

Table 23 Western Europe: Male Breast Cancer Market, by Diagnosis, 2020–2027 (USD Million)

Table 24 Western Europe: Male Breast Cancer Market, by Treatment, 2020–2027 (USD

Million)

Table 25 Eastern Europe: Male Breast Cancer Market, by Type, 2020–2027 (USD Million)

Table 26 Eastern Europe: Male Breast Cancer Market, by Diagnosis, 2020–2027 (USD Million)

Table 27 Eastern Europe: Male Breast Cancer Market, by Treatment, 2020–2027 (USD Million)

Table 28 Asia-Pacific: Male Breast Cancer Market, by Type, 2020–2027 (USD Million)

Table 29 Asia-Pacific: Male Breast Cancer Market, by Diagnosis, 2020–2027 (USD Million)

Table 30 Asia-Pacific: Male Breast Cancer Market, by Treatment, 2020–2027 (USD Million)

Table 31 Middle East & Africa: Male Breast Cancer Market, by Type, 2020–2027 (USD Million)

Table 32 Middle East & Africa: Male Breast Cancer Market, by Diagnosis, 2020–2027 (USD Million)

Table 33 Middle East & Africa: Male Breast Cancer Market, by Treatment, 2020–2027 (USD

Million)

LIST OF FIGURES

Figure 1 Research Process

Figure 2 Segmentation for Global Male Breast Cancer Market

Figure 3 Segmentation Market Dynamics for Global Male Breast Cancer Market

Figure 4 Global Male Breast Cancer Market Share, by Type, 2020

Figure 5 Global Male Breast Cancer Market Share, by Diagnosis, 2020

Figure 6 Global Male Breast Cancer Market Share, by Treatment, 2020

Figure 7 Global Male Breast Cancer Market Share, by Region, 2020

Figure 8 North America: Male Breast Cancer Market Share, by Country, 2020

Figure 9 Europe: Male Breast Cancer Market Share, by Country, 2020

Figure 10 Asia-Pacific: Male Breast Cancer Market Share, by Country, 2020

Figure 11 Middle East & Africa: Male Breast Cancer Market Share, by Country, 2020

Figure 12 Global Male Breast Cancer Market: Company Share Analysis, 2020 (%)

Figure 13 Achieve Life Sciences, Inc.: Key Financials

Figure 14 Achieve Life Sciences, Inc.: Segmental Revenue

Figure 15 Achieve Life Sciences, Inc.: Geographical Revenue

Figure 16 Pfizer Inc.: Key Financials

Figure 17 Pfizer Inc.: Segmental Revenue

Figure 18 Pfizer Inc.: Geographical Revenue

Figure 19 Eli Lily and Company: Key Financials

Figure 20 Eli Lily and Company: Segmental Revenue

Figure 21 Eli Lily and Company: Geographical Revenue

Figure 22 Bristol-Myers Squibb Company: Key Financials

Figure 23 Bristol-Myers Squibb Company: Segmental Revenue

Figure 24 Bristol-Myers Squibb Company: Geographical Revenue

Figure 25 F. Hoffman-La Roche Ltd.: Key Financials

Figure 26 F. Hoffman-La Roche Ltd.: Segmental Revenue

Figure 27 F. Hoffman-La Roche Ltd.: Geographical Revenue

Figure 28 Sanofi: Key Financials

Figure 29 Sanofi: Segmental Revenue

Figure 30 Sanofi: Geographical Revenue

Figure 31 Novartis AG: Key Financials

Figure 32 Novartis AG: Segmental Revenue

Figure 33 Novartis AG: Geographical Revenue

Figure 34 BioNumerik Pharmaceuticals Inc.: Financials

Figure 35 BioNumerik Pharmaceuticals Inc.: Segmental Revenue

Figure 36 BioNumerik Pharmaceuticals Inc.: Geographical Revenue

Figure 37 Seattle Genetics, Inc.: Key Financials

Figure 38 Seattle Genetics, Inc.: Segmental Revenue

Figure 39 Seattle Genetics, Inc.: Geographical Revenue

Figure 40 GlaxoSmithKline plc: Key Financials

Figure 41 GlaxoSmithKline plc: Segmental Revenue

Figure 42 GlaxoSmithKline plc: Geographical Revenue

Figure 43 Teva Pharmaceutical Industries Ltd.: Key Financials

Figure 44 Teva Pharmaceutical Industries Ltd.: Segmental Revenue

Figure 45 Teva Pharmaceutical Industries Ltd.: Geographical Revenue

Figure 46 Sun Pharmaceutical Industries Ltd.: Key Financials

Figure 47 Sun Pharmaceutical Industries Ltd.: Segmental Revenue

Figure 48 Sun Pharmaceutical Industries Ltd.: Geographical Revenue

Figure 49 AstraZeneca: Key Financials

Figure 50 AstraZeneca: Segmental Revenue

Figure 51 AstraZeneca: Geographical Revenue

Figure 52 Accord Healthcare: Key Financials

Figure 53 Accord Healthcare: Segmental Revenue

Figure 54 Accord Healthcare: Geographical Revenue

Figure 55 Bayer AG: Key Financials

Figure 56 Bayer AG: Segmental Revenue

Figure 57 Bayer AG: Geographical Revenue